Benzinga's Top Upgrades, Downgrades For November 30, 2018 - Abbott Laboratories (NYSE:ABT), American Woodmark (NASDAQ:AMWD)

Goldman Sachs upgraded Myriad Genetics, Inc. MYGN from Sell to Neutral. Myriad Genetics shares rose 2.1 percent to $32.72 in pre-market trading.
Citi upgraded Sony Corp SNE from Neutral to Buy. Sony rose 2 percent to $52.91 in pre-market trading.
Citigroup upgraded Nantkwest Inc NK from Sell to Neutral. NantKwest shares fell 4.02 percent to close at $1.67 on Thursday.
Analysts at Goldman Sachs upgraded Abbott Laboratories ABT from Neutral to Buy. Abbott shares rose 1.2 percent to $74.10 in pre-market trading.
Barclays upgraded Fair Isaac Corporation FICO from Equal-Weight to Overweight. Fair Isaac shares rose 2.26 percent to close at $190.44 on Thursday.
Loop Capital upgraded Coupa Software Inc COUP from Hold to Buy. Coupa Software shares rose 3.7 percent to $65.00 in pre-market trading.
JP Morgan upgraded World Wrestling Entertainment, Inc. WWE from Neutral to Overweight. WWE shares rose 4.1 percent to $75.00 in pre-market trading.
First Analysis upgraded Palo Alto Networks Inc PANW from Outperform to Strong Buy. Palo Alto shares rose 0.5 percent to $177.00 in pre-market trading.
JP Morgan upgraded Cubic Corporation CUB from Neutral to Overweight. Cubic shares fell 3.23 percent to close at $59.03 on Thursday.
Wells Fargo upgraded Under Armour Inc UAA from Underperform to Market Perform. Under Armour shares rose 1.6 percent to $23.50 in pre-market trading.

Goldman Sachs downgraded Quest Diagnostics Inc DGX from Buy to Neutral. Quest shares rose 0.4 percent to $88.25 in pre-market trading.
Bank of America downgraded Goldman Sachs Group Inc GS from Buy to Neutral. Goldman Sachs shares fell 2 percent to $190.98 in pre-market trading.
JP Morgan downgraded Cree, Inc. CREE from Neutral to Underweight. Cree shares fell 0.28 percent to close at $45.96 on Thursday.
Mizuho downgraded Assertio Therapeutics Inc ASRT from Buy to Neutral. Assertio Therapeutics shares fell 1.33 percent to close at $5.21 on Thursday.
UBS downgraded Hannon Armstrong Sustnbl Infrstr Cap Inc HASI from Buy to Neutral. Hannon Armstrong shares fell 3.2 percent to $23.00 in pre-market trading.
Goldman Sachs downgraded Waters Corporation WAT from Neutral to Sell. Waters shares fell 1.3 percent to $200.83 in pre-market trading.
Citigroup downgraded Sodexo SA SDXAY from Buy to Neutral. Sodexo shares fell 1.14 percent to close at $20.76 on Thursday.
Bank of America downgraded Sprouts Farmers Market Inc SFM from Buy to Underperform. Sprouts Farmers shares fell 11.3 percent to $23.98 in pre-market trading.
Longbow Research downgraded American Woodmark Corporation AMWD from Buy to Neutral. American Woodmark shares fell 1.55 percent to close at $66.85 on Wednesday.
DNB Markets downgraded Frontline Ltd FRO from Buy to Hold. Frontline shares fell 10.1 percent to $7.30 in pre-market trading.

Needham initiated coverage on Crispr Therapeutics AG CRSP with a Buy rating. The price target for Crispr Therapeutics is set to $62. Crispr Therapeutics shares closed at $38.72 on Thursday.
Analysts at Raymond James initiated coverage on Everi Holdings Inc EVRI with a Strong Buy rating. The price target for Everi is set to $11. Everi shares closed at $6.52 on Thursday.
H.C. Wainwright initiated coverage on Forty Seven Inc FTSV with a Buy rating. The price target for Forty Seven is set to $21. Forty Seven shares closed at $17.66 on Thursday.
Analysts at Needham initiated coverage on Casa Systems Inc CASA with a Buy rating. The price target for Casa Systems is set to $19. Casa Systems closed at $15.08 on Thursday.
Analysts at Jefferies initiated coverage on Eastgroup Properties Inc EGP with a Hold rating. The price target for Eastgroup Properties is set to $99. Eastgroup Properties shares closed at $100.23 on Thursday.